Showing results (91-100 of 170) with videos related to
Sort By:
Pageof 17
The Australasian Journal of Dermatology|July 13, 2016
The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian settingMarius Rademaker, Monisha Gupta, Megan Andrews, et al.ACS Biomaterials Science & Engineering|October 4, 2023
Layer-by-Layer Analysis of In Vitro Skin ModelsElizabeth Footner, Kate Firipis, Emily Liu, et al.The Australasian Journal of Dermatology|September 20, 2022
Dupilumab-associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian settingPeter Foley, Yves A Kerdraon, John P Hogden, et al.International Journal of Dermatology|April 14, 2015
A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosisEggert Stockfleth, Ketty Peris, Carlos Guillen, et al.American Journal of Clinical Dermatology|September 10, 2020
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 StudyKristian Reich, April W Armstrong, Peter Foley, et al.JAMA Dermatology|May 26, 2018
Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical TrialsPeter Foley, Kenneth Gordon, Christopher E M Griffiths, et al.Journal of the American Academy of Dermatology|January 7, 2017
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trialKristian Reich, April W Armstrong, Peter Foley, et al.The Journal of Dermatological Treatment|May 23, 2022
Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte cancersAndrew E Potter, Christopher Baker, Stephen Shumack, et al.Dermatology and Therapy|August 23, 2024
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation AnalysisApril W Armstrong, Peter Foley, Yan Liu, et al.The Australasian Journal of Dermatology|June 3, 2015
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in AustraliaJo-Ann See, Stephen Shumack, Dedee F Murrell, et al.Pageof 17